J.P. Bercu
Advertisement
J.P. Bercu is senior director in nonclinical safety and pathobiology, Gilead Sciences.
Articles by J.P. Bercu
Advertisement
Latest Updated Articles
Managing the Risk of Nitrosamine ImpuritiesMarch 15th 2021
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
MASH and Cardiomyopathy Targets: Why AstraZeneca Chose insitro’s AI
2
Germany’s Medical Biotechnology Sector is Flourishing
3
First-in-Human Trial Speed: Why FDA Trails China
4
Formulation Strategies for Next-Generation Multiagonists
5